Why cardiovascular mortality is higher in treated hypertensives versus subjects of the same age, in the general population
- 1 September 2003
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Hypertension
- Vol. 21 (9), 1635-1640
- https://doi.org/10.1097/00004872-200309000-00011
Abstract
The aim of the present study was to assess whether increased cardiovascular mortality in treated hypertensives could be explained by high blood pressure levels, or by the presence of associated risk factors and/or associated diseases. The study sample consisted of 8893 treated hypertensive men and women from the Investigations Préventives et Cliniques cohort, and 25880 gender-matched and age-matched untreated subjects from the same cohort. Vital status was obtained for an 8-12 year period. Treated hypertensive subjects had higher systolic blood pressure (SBP) (+ 15 mmHg) and higher diastolic blood pressure (+ 9 mmHg), and a higher prevalence of associated risk factors and diseases. Treated hypertensives compared with untreated subjects presented a two-fold increase in the risk ratio (RR) for cardiovascular mortality [RR, 1.96; 95% confidence interval (CI), 1.74-2.22] and coronary mortality (RR, 1.99; 95% CI, 1.63-2.44). Adjustment for unmodifiable risk factors decreased the excess cardiovascular risk observed in treated subjects only slightly: RR, 1.77; 95% CI, 1.56-2.00 for cardiovascular mortality; and RR, 1.76; 95% CI, 1.44-2.16 for coronary mortality. After additional adjustment for modifiable associated risk factors, the increased mortality in treated subjects persisted: RR, 1.52; 95% CI, 1.33-1.74 for cardiovascular mortality; and RR, 1.49; 95% CI, 1.19-1.86 for coronary mortality. Only after additional adjustment for SBP were cardiovascular mortality and coronary mortality similar in the two groups of subjects: RR, 1.06; 95% CI, 0.92-1.23; and RR, 1.06; 95% CI, 0.85-1.35, respectively. The increased cardiovascular mortality in treated hypertensive subjects as compared with untreated subjects is mainly due to high SBP levels under treatment. This result suggests that the excess risk found in treated hypertensives may be drastically reduced if SBP were brought under control.This publication has 13 references indexed in Scilit:
- Survey on treatment of hypertension and implementation of World Health Organization/International Society of Hypertension risk stratification in primary care in BelgiumJournal of Hypertension, 2002
- Prognostic value of systolic and diastolic blood pressure in treated hypertensive men.Archives of Internal Medicine, 2002
- Impact of the Gubbio population study on community control of blood pressure and hypertensionJournal of Hypertension, 2001
- Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)The Lancet, 2000
- A decrease in diastolic blood pressure combined with an increase in systolic blood pressure is associated with a higher cardiovascular mortality in menJournal of the American College of Cardiology, 2000
- Survival in treated hypertension: follow up study after two decadesBMJ, 1998
- Distribution and determinants of cardiovascular events during 20 years of successful antihypertensive treatmentJournal of Hypertension, 1998
- Hypertension awareness, treatment and control in the community: is the ‘rule of halves’ still valid?Journal of Human Hypertension, 1997
- Trends in the Prevalence, Awareness, Treatment, and Control of Hypertension in the Adult US PopulationHypertension, 1995
- Mortality in Patients of the Glasgow Blood Pressure ClinicJournal of Hypertension, 1986